FDA
- Status: approved
🇺🇸 recombinant B-type, natriuretic peptide in United States
recombinant B-type, natriuretic peptide (recombinant B-type, natriuretic peptide) regulatory status in United States.
Marketing authorisation
recombinant B-type, natriuretic peptide in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in United States
Frequently asked questions
Is recombinant B-type, natriuretic peptide approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for recombinant B-type, natriuretic peptide in United States?
University of Texas Southwestern Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.